THURSDAY, Sept. 19, 2024 (HealthDay News) — A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream andContinue Reading
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to moreContinue Reading
TUESDAY, Sept. 17, 2024 (HealthDay News) — As wildfires continue to burn across parts of California, a new study finds that smoke from these blazes and other air pollution could be harming kids’ mental health. Repeated exposure to high levels of particle pollution increases kids’ risk of depression, anxiety andContinue Reading
TUESDAY, Sept. 17, 2024 (HealthDay News) — Brain training aimed at improving memory can ward off symptoms of Alzheimer’s disease for years, a new study claims. Seniors experienced a slower decline in their memory and thinking abilities after undergoing brain training, compared to others who didn’t get the training, researchersContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — For the first time, scientists have detected microscopic microplastics lodged in the human brain. Researchers in Germany and Brazil say that 8 out of 15 autopsied adults had microplastics detected within their brain’s smell centers, the olfactory bulb. The particles were likely breathedContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — People with rare genetic variants linked to degenerative brain disorders like Parkinson’s disease are at increased risk of developing ALS, a new study finds. Further, having these genetic variants increases the risk of a person having faster-progressing ALS (amyotrophic lateral sclerosis) and dyingContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Vaping may look cool when you’re young, but it appears to be dulling the brains of college students, a new study warns. College students who vape have lower cognitive function scores than those who don’t, researchers reported Sunday at the American Neurological Association’sContinue Reading
MONDAY, Sept. 16, 2024 (HealthDay News) — Newfangled designs intended to make football helmets more protective have overlooked one key component, a new study suggests. Nearly a third of concussions in pro football involve impacts to the facemask, a part of the helmet that has remained mostly unchanged during theContinue Reading
FRIDAY, Sept. 13, 2024 (HealthDay News) — One third of cinnamon products tested by Consumer Reports contained elevated levels of lead, the watchdog agency warned Thursday. The finding follows concerns about metals in foods after tainted cinnamon applesauce poisoned hundreds in 44 states last year, most of them children. InContinue Reading
THURSDAY, Sept. 11, 2024 (HealthDay News) — Two monoclonal antibody treatments to slow Alzheimer’s disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years. It’s thought the drugs curb Alzheimer’s by reducing levels of toxic amyloid protein plaques inContinue Reading